AU1716995A - Aqueous solution of levocabastine for ophthalmic use - Google Patents

Aqueous solution of levocabastine for ophthalmic use

Info

Publication number
AU1716995A
AU1716995A AU17169/95A AU1716995A AU1716995A AU 1716995 A AU1716995 A AU 1716995A AU 17169/95 A AU17169/95 A AU 17169/95A AU 1716995 A AU1716995 A AU 1716995A AU 1716995 A AU1716995 A AU 1716995A
Authority
AU
Australia
Prior art keywords
levocabastine
aqueous solution
ophthalmic use
ophthalmic
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17169/95A
Inventor
Ramon L Espino
Gene F Tutwiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU1716995A publication Critical patent/AU1716995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
AU17169/95A 1994-03-18 1995-03-08 Aqueous solution of levocabastine for ophthalmic use Abandoned AU1716995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21452394A 1994-03-18 1994-03-18
US214523 1994-03-18
PCT/IB1995/000143 WO1995025518A1 (en) 1994-03-18 1995-03-08 Aqueous solution of levocabastine for ophthalmic use

Publications (1)

Publication Number Publication Date
AU1716995A true AU1716995A (en) 1995-10-09

Family

ID=22799401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17169/95A Abandoned AU1716995A (en) 1994-03-18 1995-03-08 Aqueous solution of levocabastine for ophthalmic use

Country Status (4)

Country Link
AU (1) AU1716995A (en)
IL (1) IL112947A0 (en)
WO (1) WO1995025518A1 (en)
ZA (1) ZA952203B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006137433A1 (en) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation having levocabastine solubilized therein
JP5275214B2 (en) 2006-03-17 2013-08-28 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド Ophthalmic stable composition comprising an oxidatively unstable component
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
WO1992005783A1 (en) * 1990-09-28 1992-04-16 Merck & Co., Inc. Ibuprofen-antihistamine combinations
AU678561B2 (en) * 1992-10-09 1997-06-05 Procter & Gamble Company, The Pharmaceutical compositions and methods for treating cold symptoms

Also Published As

Publication number Publication date
ZA952203B (en) 1995-09-18
IL112947A0 (en) 1995-06-29
WO1995025518A1 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
AU1645595A (en) Disposable diaper
AU7194596A (en) Disposable diaper
AU6810496A (en) Disposable diaper
AU3917995A (en) Teeth-coating liquid
AU1166295A (en) Skin cleansing compositions
AU2041195A (en) Process of sterilization
AU7905894A (en) Treatment of poultry
PL318132A1 (en) Aqueous preparations of risperidone
AU4878996A (en) Liquid cleansing formulations
AU6810396A (en) Disposable diaper
AU6034096A (en) Disposable applicator
AU1911095A (en) Aqueous indolocarbazole solutions
AU2670695A (en) Preparation of purines
AU2467395A (en) Novel ophthalmologic uses of protein c
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU5357696A (en) Disposable diaper
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU3455393A (en) Preparation for skin use
AU2473295A (en) An improved ocular care solution
AU2809895A (en) Aqueous cleaning composition
AU5677596A (en) Improved aqueous absorption fluids
AU1716995A (en) Aqueous solution of levocabastine for ophthalmic use
AU1181897A (en) Medical use of proteases
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AU4706396A (en) Aqueous cleaning composition